Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay

Transfusion

Volumn 53, Issue 9, 2013, Pages 1940-1947

  Gandhi, Manish J ^a   Carrick, Danielle M ^a   Jenkins, Sarah ^a   De Goey, Steven ^a   Ploeger, Nancy A ^a   Wilson, Gregory A ^a   Lee, Jar How ^a   Winters, Jeffrey L ^a   Stubbs, James R ^a   Toy, Pearl ^a   Norris, Philip J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; HLA SYSTEM; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MULTIPLEX BEAD BASED ASSAY;

ACUTE LUNG INJURY; ANTIBODIES; BIOLOGICAL ASSAY; BLOOD DONORS; HLA ANTIGENS; HUMANS; MALE;

EID: 84883878196     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12064     Document Type: Article

References (25)

1. Popovsky MA, Abel MD, Moore SB,. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983; 128: 185-189.
2. Popovsky MA, Moore SB,. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573-577.
3. Triulzi DJ,. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg 2009; 108: 770-776.
4. FDA/Center for Biologics Evaluation and Research, US Department of Health & Human Services. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2009 [monograph on the internet]. 2010. [cited 2012 Dec 11]. Available from: URL http://www.fda.gov/downloads/ BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/ TransfusionDonationFatalities/UCM205620.pdf.
5. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CC, Stroncek D,. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005; 33: 721-726.
6. Silliman CC, Moore EE, Kelher MR, Khan SY, Gellar L, Elzi DJ,. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011; 51: 2549-2554.
7. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR,. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454-462.
8. Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH,. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003; 43: 641-645.
9. Silliman CC, Curtis BR, Kopko PM, Khan SY, Kelher MR, Schuller RM, Sannoh B, Ambruso DR,. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007; 109: 1752-1755.
10. Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A,. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 1996; 93: 707-713.
11. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB,. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007; 176: 886-891.
12. Triulzi DJ, Kakaiya R, Schreiber G,. Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II leukocyte antibody prevalence study (LAPS). Transfusion 2007; 47: 563-564.
13. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB,. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825-1835.
14. Strong DM, Lipton KS,. AABB Association Bulletin #06-07 [monograph on the internet]. 2006. [cited 2012 Dec 11]. Available from: URL http://www.aabb.org/ resources/publications/bulletins/Documents/ab06-07.pdf
15. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA,. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012; 119: 1757-1767.
16. Stroncek DF, Fadeyi E, Adams S,. Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions. Transfus Med Rev 2007; 21: 273-286.
17. Gottschall JL, Triulzi DJ, Curtis B, Kakaiya RM, Busch MP, Norris PJ, Glynn SA, Carrick D, Wright DJ, Kleinman S,. The frequency and specificity of human neutrophil antigen antibodies in a blood donor population. Transfusion 2011; 51: 820-827.
18. Pei R, Lee J, Chen T, Rojo S, Terasaki PI,. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol 1999; 60: 1293-1302.
19. Gandhi MJ, Ploeger NA, Wilson GA, DeGoey S, Stubbs J, Norris PJ, Winters JL, Toy P,. Lot-to-lot variability of HLA antigen specificities on solid phase antibody detection assay: relevance to blood donor screening. Transfusion 2010; 50: 123A-124.
20. Carrick DM, Norris PJ, Endres RO, Pandey S, Kleinman SH, Wright D, Sun Y, Busch MP,. Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion 2011; 51: 2092-2101.
21. Norris PJ, Lee JH, Carrick DM, Gottschall JL, Lebedeva M, de, Castro BR, Kleinman SH, Busch MP,. Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma. Transfusion 2009; 49: 243-251.
22. One Lamba, Inc. Labscreen™ Mixed Datasheet. Canoga Park (CA): One Lambda Inc.
23. Powers A, Stowell CP, Dzik WH, Saidman SL, Lee H, Makar RS,. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion 2008; 48: 2549-2558.
24. Makar RS, Saidman SL, Stowell CP, Lee H, Powers A,. Analysis of cutoffs for screening sensitized blood donors for HLA alloantibodies using a cytometric microbead assay. Transfusion 2011; 51: 166-174.
25. Gebel HM, Bray RA,. The evolution and clinical impact of human leukocyte antigen technology. Curr Opin Nephrol Hypertens 2010; 19: 598-602.